X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (66) 66
humans (64) 64
cardiac & cardiovascular systems (36) 36
clopidogrel (36) 36
female (29) 29
male (29) 29
middle aged (29) 29
cardiovascular (27) 27
percutaneous coronary intervention (26) 26
ticlopidine - analogs & derivatives (24) 24
treatment outcome (24) 24
prasugrel (23) 23
aged (22) 22
hematology (21) 21
mortality (21) 21
peripheral vascular disease (21) 21
acute coronary syndrome (19) 19
platelet aggregation inhibitors - therapeutic use (19) 19
thrombosis (19) 19
risk factors (18) 18
acute coronary syndromes (17) 17
cardiac patients (17) 17
abridged index medicus (16) 16
blood platelets - drug effects (15) 15
heart attacks (15) 15
platelet function tests (15) 15
antiplatelet therapy (14) 14
bleeding (14) 14
drug therapy (14) 14
platelet function testing (14) 14
ticagrelor (14) 14
analysis (13) 13
stent thrombosis (13) 13
internal medicine (12) 12
platelet aggregation inhibitors - administration & dosage (12) 12
stents (12) 12
ticlopidine - therapeutic use (12) 12
transluminal angioplasty (12) 12
platelet aggregation inhibitors - adverse effects (11) 11
platelet reactivity (11) 11
prognosis (11) 11
prospective studies (11) 11
acute coronary syndrome - drug therapy (10) 10
blood platelets - metabolism (10) 10
cardiology (10) 10
platelet aggregation - drug effects (10) 10
platelets (10) 10
purinergic p2y receptor antagonists - adverse effects (10) 10
purinergic p2y receptor antagonists - therapeutic use (10) 10
ticlopidine - administration & dosage (10) 10
acute coronary syndrome - therapy (9) 9
aspirin (9) 9
high platelet reactivity (9) 9
risk assessment (9) 9
therapy (9) 9
time factors (9) 9
aggregation (8) 8
blood platelets (8) 8
clinical-outcomes (8) 8
coronary heart disease (8) 8
follow-up studies (8) 8
hemorrhage - chemically induced (8) 8
intervention (8) 8
metaanalysis (8) 8
myocardial infarction (8) 8
percutaneous coronary intervention - adverse effects (8) 8
purinergic p2y receptor antagonists - administration & dosage (8) 8
acute coronary syndrome - diagnosis (7) 7
acute coronary syndrome - mortality (7) 7
angioplasty (7) 7
cardiology and cardiovascular medicine (7) 7
care and treatment (7) 7
dose-response relationship, drug (7) 7
myocardial-infarction (7) 7
patients (7) 7
platelet function tests - methods (7) 7
platelet inhibition (7) 7
predictive value of tests (7) 7
stent (7) 7
ticlopidine - adverse effects (7) 7
acute coronary syndrome - blood (6) 6
adult (6) 6
angioplasty, balloon, coronary - methods (6) 6
cardiovascular diseases (6) 6
cell biology (6) 6
clinical medicine (6) 6
clopidogrel-treated patients (6) 6
drug administration schedule (6) 6
drug-eluting stents (6) 6
elevation myocardial-infarction (6) 6
events (6) 6
implantation (6) 6
inhibition (6) 6
medicine, general & internal (6) 6
outcome (6) 6
patient outcomes (6) 6
pci (6) 6
platelet aggregation inhibitors - pharmacology (6) 6
prevention (6) 6
receptors, purinergic p2y12 - drug effects (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 2017, Volume 117, Issue 5, pp. 823 - 825
Journal Article
by Sibbing, Dirk and Aradi, Dániel and Aradi, Daniel and Jacobshagen, Claudius and Gross, Lisa and Trenk, Dietmar and Geisler, Tobias and Orban, Matthias and Orban, Martin and Hadamitzky, Martin and Merkely, Béla and Kiss, Róbert Gábor and Komócsi, András and Dézsi, Csaba A and Dézsi, Csaba András and Dézsi, András Döme and Holdt, Lesca and Felix, Stephan and Felix, Stephan B and Parma, Zofia and Parma, Radoslaw and Klopotowski, Mariusz and Schwinger, Robert and Schwinger, Robert H G and Rieber, Johannes and Huber, Kurt and Neumann, Franz-Josef and Koltowski, Lukasz and Mehilli, Julinda and Huczek, Zenon and Massberg, Steffen and Lesiak, Maciej and Komosa, Anna and Kowara, Michal and Rymuza, Bartosz and Malek, Lukasz and Veress, Gábor and Lux, Árpád and Papp, Judit and Kovács, Andrea and Amer, Sayour and Ruzsa, Zoltán and Róna, Szilárd and Ili, Renáta and Ungi, Imre and Nagy, Ferenc and Zweiker, Robert and Tóth-Gayor, Gábor and Haller, Paul and von Scheidt, Wolfgang and Blüthgen, Andreas and Leggewie, Stefan and Kreider-Stempfle, Hans Ulrich and Remp, Thomas and Kara, Kaffer and Mügge, Andreas and Wutzler, Alexander and Fichtlscherer, Stephan and Zeiher, Andreas M and Seeger, Florian and Hinterseer, Martin and König, Andreas and Lederle, Susanne and Czepluch, Frauke and Maier, Lars and Schillinger, Wolfgang and Sossalla, Samuel and Hummel, Astrid and Karakas, Mahir and Sydow, Karsten and Rudolph, Tanja and Halbach, Marcel and Gori, Tommaso and Münzel, Thomas and May, Andreas and Gerstenberg, Carsten-Manuel and Pilecky, David and Deichstetter, Markus and Kääb, Stefan and Löw, Anja and Sattler, Stefan and Deuschl, Sabine and Teupser, Daniel and Mudra, Harald and Räder, Thomas and Schütz, Torsten and Vahldiek, Felix and Divchev, Dimitar and Ince, Hüseyin and Nienaber, Christoph A and Radunski, Henning and Boekstegers, Peter and Horstkotte, Jan and Mueller, Ralf and Müller, Karin and Rasp, Oliver and TROPICAL-ACS Investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1747 - 1757
Current guidelines recommend potent platelet inhibition with prasugrel or ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous... 
ELUTING STENTS | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | THERAPY | TICAGRELOR | TREATMENT PATTERNS | ACADEMIC RESEARCH CONSORTIUM | PRASUGREL | DIPHOSPHATE RECEPTOR INHIBITOR | MYOCARDIAL-INFARCTION PATIENTS | PLATELET REACTIVITY | Myocardial Infarction - epidemiology | Acute Coronary Syndrome - epidemiology | Drug Administration Schedule | Hemorrhage - epidemiology | Humans | Middle Aged | Europe - epidemiology | Male | Prasugrel Hydrochloride - adverse effects | Ticlopidine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Acute Coronary Syndrome - therapy | Clopidogrel | Female | Stroke - epidemiology | Hemorrhage - chemically induced | Prasugrel Hydrochloride - administration & dosage | Drug Monitoring | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Care and treatment | Coronary heart disease | Cardiac patients | Analysis | Anticoagulants | Heart attacks | Blood platelets | Angioplasty | Clinical trials | Acute coronary syndromes | Drug therapy | Patients | Clinical outcomes | Myocardial infarction | Intervention | Medical services | Bleeding | Consortia | Randomization | Motivation | Inhibition | Cerebral infarction | Stroke | Test procedures | Health risks | Thrombosis | Coronary vessels | Biomarkers | Infarction | Cardiovascular diseases | Platelets
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 3, pp. 543 - 551
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 64, Issue 3, p. 334
  [...]the authors claim it unethical to use clopidogrel in patients with ST-segment elevation myocardial infarction (STEMI). 
Genotype & phenotype | Heart attacks | Acute coronary syndromes | Thrombosis
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 64, Issue 3, p. 334
Journal Article
Review of Scientific Instruments, ISSN 0034-6748, 03/2019, Volume 90, Issue 3, p. 033501
Atomic beam probe is an extension of the routinely used beam emission spectroscopy diagnostic for the plasma edge current fluctuation measurement at... 
INSTRUMENTS & INSTRUMENTATION | PHYSICS, APPLIED | Plasma | Curved beams | Atomic beams | Ion bombardment | Crosstalk | Ion currents | Variations | Tokamak devices | Ion beams | Cups | Current distribution | Plasma radiation | Diagnostic systems | Plasma currents | Sensors | Plasmas | Magnetic fields | Lithium ions | Electron bombardment | Electrons | Physics - Plasma Physics
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2013, Volume 109, Issue 1, pp. 93 - 101
SummaryAdministration of a P2Y12-receptor antagonist in addition to aspirin is mandatory in patients with acute coronary syndromes (ACS) or undergoing... 
Prasugrel | Stroke | receptor | P2Y | Clopidogrel | Platelet inhibition | Ticagrelor
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 17, pp. B219 - B219
  Methods Electronic databases were searched to find prospective, randomized, placebo-controlled clinical trials (RCT) that evaluated the clinical impact of... 
Cardiovascular | Internal Medicine | Care and treatment | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Anticoagulants | Heart attacks | Acute coronary syndromes | Drug therapy | Angina pectoris
Journal Article
Archives of Medical Science, ISSN 1734-1922, 2014, Volume 10, Issue 2, pp. 203 - 212
Introduction: Superior outcomes with transradial (TRPCI) versus transfemoral coronary intervention (TFPCI) in the setting of acute ST-segment elevation... 
Death | Transfemoral | ST-segment elevation myocardial infarction | Transradial | RADIAMI | EVENTS | death | FEMORAL APPROACH | SAFETY | TRANSRADIAL APPROACH | TRANSFEMORAL APPROACH | ARTERIAL ACCESS | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | IMPACT | ANGIOPLASTY | transfemoral | transradial | Systematic review | Meta-analysis
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2016, Volume 115, Issue 4, pp. 844 - 855
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2014, Volume 63, Issue 11, pp. 1161 - 1170
Journal Article